There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Closed, Sticky:
New Resources for 1000 Genomes
|
35 responses
108,029 views
0 reactions
|
by laura
12-05-2013, 02:37 AM
|
||
|
Closed, Sticky:
Software packages for next gen sequence analysis
|
236 responses
688,238 views
1 reaction
|
by ECO
12-25-2009, 06:45 PM
|
||
|
0 responses
2,669 views
0 reactions
|
by Olha
02-10-2016, 03:09 PM
|
|||
|
14 responses
30,871 views
0 reactions
|
by clintp
02-10-2016, 11:54 AM
|
|||
|
6 responses
4,751 views
0 reactions
|
by KevinLam
02-10-2016, 08:45 AM
|
|||
|
15 responses
5,817 views
0 reactions
|
by GenoMax
02-10-2016, 05:09 AM
|
|||
|
0 responses
1,882 views
0 reactions
|
by Macspider
02-10-2016, 02:22 AM
|
|||
|
0 responses
1,178 views
0 reactions
|
by SMusker
02-10-2016, 12:56 AM
|
|||
|
0 responses
1,307 views
0 reactions
|
by Niranjanks
02-10-2016, 12:15 AM
|
|||
|
5 responses
2,574 views
0 reactions
|
by GenoMax
02-09-2016, 04:43 PM
|
|||
|
0 responses
1,589 views
0 reactions
|
by umn_bist
02-09-2016, 01:48 PM
|
|||
|
0 responses
4,978 views
0 reactions
|
by MQ-BCBB
02-09-2016, 10:46 AM
|
No topics found.
-
Next-generation sequencing (NGS) is changing how clinical and public health laboratories detect pathogens, track antimicrobial resistance,...Yesterday, 05:37 AM -
Much of the genetic basis of Alzheimer's disease and related dementias (AD/ADRD) is still unexplained, and some of the answers may sit...Yesterday, 05:06 AM
-
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing... -
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM